Compare LTRN & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTRN | NXPL |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6M | 24.3M |
| IPO Year | 2020 | 2011 |
| Metric | LTRN | NXPL |
|---|---|---|
| Price | $1.51 | $9.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 158.1K | 34.2K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.65 | ★ 35.29 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,869,558.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.50 |
| 52 Week Low | $1.11 | $0.34 |
| 52 Week High | $4.70 | $9.94 |
| Indicator | LTRN | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 25.68 | 63.32 |
| Support Level | $1.11 | $8.70 |
| Resistance Level | $2.41 | $9.94 |
| Average True Range (ATR) | 0.15 | 0.54 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 3.11 | 63.50 |
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.